A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.

Clinical trial NCT00232856 · COMPLETED

Trial details

NCT number: NCT00232856
Sponsor: Cordis US Corp.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2002-12-01
Primary completion: 2003-12-01
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.